PUBLIC CONTRACT · 2019
61040619 - AQ Urgente - Medicamentos
- Contract value
- €8,949.30
- Signed on
- 19 November 2019
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6058674PUBLISHED SUBJECT
Nicotina 14 mg/24 h Sist transd BETAMETASONA 1 MG/G CR BISN 30 G Carboximaltose férrica 50 mg/ml Sol inj Fr 10 ml IV Corante com luteina 20mg/ml+ azul brilhante 0,5mg/ml+ azul tripano 1,5mg/ml amp.
Parties involved
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- OM PHARMA S.A. · Tax ID 500207410
- Awardee
- Neolife Wizard, S.A. · Tax ID 513635882
- Awardee
- Perrigo, Lda. · Tax ID 506112233
- Awardee
- MERCK SHARP DOHME · Tax ID 500191360
Values and timeline
- Contract price
- €8,949.30
- Procedure base price
- €8,949.30
- Total effective price
- Not reported on Portal BASE
- Publication date
- 26 November 2019
- Award date
- 19 November 2019
- Signing date
- 19 November 2019
- Performance period
- 10 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2016/18 - Acordo quadro para fornecimento de Medicamentos do Grupo 4: Sangue às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4277475
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.